QuantalX Neuroscience LTD

QuantalX Neuroscience LTD is a medical device company focused on brain health diagnostics. Founded by neuroscientists, the company aims to improve the diagnosis and care of neurodegenerative and brain disorders, including dementia, Alzheimer's, and stroke. Their flagship product, Delphi-MD, is a non-invasive system that visualizes brain health without requiring patient participation. It measures brain network responses using a magnetic probe, providing real-time assessments that enhance clinical decision-making. The team at QuantalX includes experienced professionals from neuroscience, medicine, and technology, supported by advisors with expertise in various fields. The company collaborates with academic and medical institutions to conduct clinical studies, demonstrating the potential of Delphi-MD in predicting neurological deterioration and evaluating brain changes in different conditions. QuantalX targets neurologists and healthcare systems, offering precise neuro-physiological assessments to improve patient management. Their FDA-approved technology highlights its reliability and compliance in the medical field.

• Employees 21